A randomized controlled clinical trial will be carried out using inspiratory and expiratory training devices on healthy subjects recruited in social networks and university environments. The aim will be to determine the effectiveness and safety in the prevention and severity of COVID-19 disease by a respiratory training with inspiratory and expiratory devices.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
240
Inspiratory training by a Power-breath device
Expiratory training a Winner-flow device
COVID-19 disease diagnosis
Dichotomous categorical variable measured by "yes" or "no" responses
Time frame: Change from Baseline COVID-19 disease diagnosis at 8 weeks
COVID-19 disease symptoms severity
Dichotomous categorical variable measured by "slight" or "severe" responses
Time frame: Change from Baseline COVID-19 disease symptoms severity at 8 weeks
Adverse effects
Polytomous categorical variable measured by adverse effects responses
Time frame: Change from Baseline adverse effects at 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.